Polymerase Chain Reaction Test for Clostridium difficile Toxin B Gene Reveals Similar Prevalence Rates in Children With and Without Inflammatory Bowel Disease
- 1 September 2013
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 57 (3) , 293-297
Abstract
Objective: Clinicians often evaluate for Clostridium difficile infection (CDI) in patients with inflammatory bowel disease (IBD) presenting with exacerbations. A highly sensitive polymerase chain reaction (PCR) test for the toxin B gene of C difficile is increasingly used to diagnose CDI. The aim of this study was to determine the prevalence of positive C difficile PCR results in children and young adults with and without active IBD compared with patients with non‐IBD gastrointestinal disease.Methods: Fecal samples were obtained from patients with ulcerative colitis (UC, n = 76) or Crohn disease (CD, n = 69) and 51 controls followed in our gastroenterology program. Samples were analyzed for C difficile using a PCR test for the C difficile toxin B gene (BD GeneOhm Cdiff assay). Proportions of positive tests in each group were compared using the Pearson χ2 test.Results: The prevalence of positive PCR results was 11.6% in patients with CD, 18.4% in patients with UC, and 11.8% in controls (P = 0.25). There were no significant differences in the prevalence of positive C difficile results among patients with IBD with and without active disease or among patients with and without diarrhea.Conclusions: Positive C difficile PCR results occur with similar frequency in patients with IBD with and without active disease and in patients with other gastrointestinal diseases. A positive result in a highly sensitive PCR assay that detects low copy numbers of a toxin gene in C difficile may reflect colonization in a subset of patients with IBD, confounding clinical decision making in managing disease exacerbations.Keywords
Funding Information
- Robert Wood Johnson Foundation
This publication has 31 references indexed in Scilit:
- Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel DiseasePLOS ONE, 2012
- Clostridium difficile Infection and Treatment in the Pediatric Inflammatory Bowel Disease PopulationJournal of Pediatric Gastroenterology and Nutrition, 2011
- Genetics and Environmental Interactions Shape the Intestinal Microbiome to Promote Inflammatory Bowel Disease Versus Mucosal HomeostasisGastroenterology, 2010
- Microbiota in Pediatric Inflammatory Bowel DiseaseThe Journal of Pediatrics, 2010
- Clostridium difficileinfection and inflammatory bowel disease: Understanding the evolving relationshipWorld Journal of Gastroenterology, 2010
- Clostridium difficileinfection and inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2009
- Impact of Clostridium difficile Infection on Pediatric Inflammatory Bowel DiseaseThe Journal of Pediatrics, 2009
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Clostridium difficile in Inflammatory Bowel Disease RelapseJournal of Pediatric Gastroenterology and Nutrition, 1991
- Lack of Relationship between Clostridium difficile Toxin and Inflammatory Bowel Disease in ChildrenJournal of Clinical Gastroenterology, 1985